Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 2
1977 1
1984 1
1991 2
1992 2
1993 1
1994 3
1996 2
1997 7
1998 2
1999 4
2000 3
2001 5
2002 4
2003 4
2004 6
2005 2
2006 4
2007 2
2008 3
2009 3
2010 4
2011 8
2012 12
2013 9
2014 9
2015 6
2016 11
2017 8
2018 8
2019 6
2020 3
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

131 results
Results by year
Filters applied: . Clear all
Page 1
Unexpected High Levels of BRN2/POU3F2 Expression in Human Dermal Melanocytic Nevi.
Chitsazan A, Lambie D, Ferguson B, Handoko HY, Gabrielli B, Walker GJ, Boyle GM. Chitsazan A, et al. Among authors: gabrielli b. J Invest Dermatol. 2020 Jun;140(6):1299-1302.e4. doi: 10.1016/j.jid.2019.12.007. Epub 2019 Dec 24. J Invest Dermatol. 2020. PMID: 31881210 Free article. No abstract available.
Multiple interaction nodes define the postreplication repair response to UV-induced DNA damage that is defective in melanomas and correlated with UV signature mutation load.
Pavey S, Pinder A, Fernando W, D'Arcy N, Matigian N, Skalamera D, Lê Cao KA, Loo-Oey D, Hill MM, Stark M, Kimlin M, Burgess A, Cloonan N, Sturm RA, Gabrielli B. Pavey S, et al. Among authors: gabrielli b. Mol Oncol. 2020 Jan;14(1):22-41. doi: 10.1002/1878-0261.12601. Epub 2019 Dec 19. Mol Oncol. 2020. PMID: 31733171 Free PMC article.
Combined use of subclinical hydroxyurea and CHK1 inhibitor effectively controls melanoma and lung cancer progression, with reduced normal tissue toxicity compared to gemcitabine.
Oo ZY, Proctor M, Stevenson AJ, Nazareth D, Fernando M, Daignault SM, Lanagan C, Walpole S, Bonazzi V, Škalamera D, Snell C, Haass NK, Larsen JE, Gabrielli B. Oo ZY, et al. Among authors: gabrielli b. Mol Oncol. 2019 Jul;13(7):1503-1518. doi: 10.1002/1878-0261.12497. Epub 2019 Jun 14. Mol Oncol. 2019. PMID: 31044505 Free PMC article.
Endogenous Replication Stress Marks Melanomas Sensitive to CHEK1 Inhibitors In Vivo.
Oo ZY, Stevenson AJ, Proctor M, Daignault SM, Walpole S, Lanagan C, Chen J, Škalamera D, Spoerri L, Ainger SA, Sturm RA, Haass NK, Gabrielli B. Oo ZY, et al. Among authors: gabrielli b. Clin Cancer Res. 2018 Jun 15;24(12):2901-2912. doi: 10.1158/1078-0432.CCR-17-2701. Epub 2018 Mar 13. Clin Cancer Res. 2018. PMID: 29535131 Free article.
131 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page